Patient 1
A 19-year-old female was initially admitted to the surgical unit of the Royal Alexandra Infirmary on 30 January, 1966 . Her complaint was of 3 days' abdominal pain, vomiting and constipation. The constipation had been present for several days prior to the other symptoms. The first clinical impression was of simple constipation and she was treated with purgatives; pethidine was given for the abdominal pain. On 1 February she had an epileptiform seizure, apparently her first, and a few days later, when it was discovered that her twin sister was suffering from a similar illness, a more detailed family history revealed her to be a cousin of a known case of acute intermittent porphyria. The diagnosis was quickly established by testing the urine for porphobilinogen with Ehrlich's reagent.
On transfer to the medical wards, her history was reviewed and it became apparent that the illness dated from her attendance at a party 3 days previously when she took alcohol for the first time. During the next 2 days 50 mg of butobarbitone were ingested on four occasions because she felt unwell.
On examination she was a thin, pale young woman, normally developed, afebrile but with a persistent sinus tachycardia of 120/min. The cardiovascular system was otherwise normal, the blood pressure being 120/90 mmHg. On Like her sister, the onset of symptoms dated from the same party at which she also had taken alcohol for the first time. Again, like her sister, she had taken butobarbitone in a dose of 100 mg on two occasions.
On examination she was a thin pale young woman, identical in appearance to her twin. She had a persistent sinus tachycardia. The cardiovascular system was otherwise normal, blood pressure 130/90 mmHg. Neurological examination revealed diminished muscle power in her legs and all tendon reflexes were absent. Sensation was unimpaired. Examination of respiratory and alimentary systems was normal. Serial laboratory investigations are listed in Table 2 . She too has had no recurrence of symptoms since the initial illness.
Further investigations Family studies
The diagnosis was reached by reason of a known relationship to a case of porphyria. Further investigation showed that three relatives, a paternal aunt, Fig. 1 was no evidence of chromosome breakage or rearrangements and the karyotype was within normal limits. The chromosome abnormality has not been shown in any of the relatives tested.
Effect of alcohol
The patients were admitted on 19 August, 1968 to the metabolic ward ofthe Department of Medicine, Western Infirmary, Glasgow. Both were given exactly the same ward diet. Daily estimation of erythrocyte porphyrins was carried out and all urine and faeces was collected for 6 days for measurement of porphyrin output. Both patients were clinically well during the period of investigation.
In view ofthe possible precipitation of symptoms in both cases by the ingestion of alcohol, we investigated the effect of alcohol on porphyrin production in one twin, using the other as a control. After 3 control days, one of the patients, Case 2, was asked to drink 50 ml of whisky (16 g absolute alcohol), and collections were taken for a further 3 days. Tables 3 and 4 show the urinary porphyrins, 8-aminolaevulic acid and porphobilinogen on each of the 6 days of collection. The only change noted was a tenfold increase in excretion of urinary coproporphyrin in Case 2 on the second day after ingestion of alcohol. The rise is statistically significant (P < 0 01).
Comment
Kehoe, Rudensky & Reynolds (1957), described Franke & Fimkemtscher (1935) who showed that the administration ofalcohol to healthy men and to chronic alcoholic subjects increased the excretion of urinary coproporphyrin. The clinical relationship of alcohol to porphyria cutanea tarda symptomatica in the cases described by Eales (1963) in South Africa is suggested by the almost invariable finding ofchronic alcoholism in patients with this disorder.
In our patients, the role of alcohol as a precipitating agent for the clinical manifestations is obscured by the fact that in both cases barbiturate drugs were taken prior to hospital aamission, though after the onset of symptoms. Barbitura.es are of course well documented precipitants of acute intermittent porphyria as Goldberg (1959) has shown. We have demonstrated a significant elevation of urinary coproporphyrin in one of our patients after ingestion of alcohol although the patient remained asymptomatic.
The mechanism by which alcohol influences porphyrin metabolism is not clear. Shanley, Zail & Joubert (1968) have demonstrated a significant rise in the hepatic level of the rate-limiting enzyme 8-aminolaevulic acid synthetase in rats to whom 5 ml of 20% ethanol was administered intraperitoneally; this elevation was maximal 3 hr after administration.
